PSORIASIS - A Mini Review
Keywords:Chronic skin disease, Inflammation, Psoriasis
Psoriasis is a chronic inflammatory squamous cell disease of papules that is characterized by multiple remissions and relapses. This has long been considered a serious violation of keratinization. The successful use of traditional immune suppressants and new immune modulators in the treatment of psoriasis has led to the belief that psoriasis is, in fact, a disorder of Th1 cell immunodeficiency. Recent developments have led to several new discoveries such as the role of Th17 cells and evidence of skin barrier dysfunction in psoriasis similar to atopic dermatitis. Psoriasis is an atypical, systemic autoimmune disease of unknown cause, mainly affecting the skin, spreading further to the nails and joints and causing arthritis. The treatment protocol should be based on the patient’s condition. People with mild psoriasis can be treated primarily with topical medications, while people with moderate to severe psoriasis can be treated with systemic medications.
How to Cite
Copyright (c) 2021 Rahul Kumar, Rajat Kumar, Rahul Anthal, Prerna, Rajat Kumar, Devkant Sharma, Anurag Bhargava
This work is licensed under a Creative Commons Attribution 4.0 International License.
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.